Latest round: Growth. Jeff Borcherding is the Chief Executive Officer and President of Immunovia AB.
Jeff Borcherding is the Chief Executive Officer and President of Immunovia AB, a Swedish diagnostic company focused on early detection of pancreatic cancer through blood-based testing. He previously served as Chief Marketing Officer at Myriad Genetics before joining Immunovia to lead its US business in April 2023. In late 2024, he announced the successful completion of a rights issue raising approximately SEK 63.2 million (over $6.1 million) to advance the company's commercialization efforts.
Full founder directory · Investor directory · Company funding database · Fundraising library